The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

In a corporate partnership many investors didn't see coming, chip maker Nvidia ( NVDA +1.59%) and pharmaceutical company Eli ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...

During Fast Company and Johns Hopkins University’s World Changing Ideas Summit last November, we asked leaders what are the ...

NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to ...

Learn about Agentic AI and its role in enhancing decision-making in drug discovery through planned actions and verified ...

New Jersey is emerging as a national leader in AI-driven life sciences, transforming health care, drug discovery and ...